small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (118)
  • Capabilities (44)
  • Experience (108)
  • Insights & News (815)
  • Other Results (36)

Professionals 118 results

Kate L. Price
Kate L. Price
Partner
  • Chicago
Email
+1 312-558-7927
vCard

Partner

  • Chicago
Conor Reidy
Conor Reidy
Partner
  • Chicago
Email
+1 312-558-7542
vCard

Partner

  • Chicago
Anthony Baker
Anthony Baker
Associate
  • Chicago
Email
+1 312-558-8133
vCard

Associate

  • Chicago
View All Professionals

Capabilities 44 results

Practice Area

Antitrust/Competition

Practice Area

Class Actions & Group Litigation

Winston has developed a consistent record of success handling class action cases in state and federal courts. The practice is anchored by seasoned class
action lawyers, many of whom have been recognized by Chambers USA and other ranking organizations as being top practitioners in their field. Our clients
rely on us to steer them through class action matters by drawing on the firm’s significant experience in resolving complex litigation using creativ...Read more
...Read more

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies
involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have
technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a uniq...Read more
...Read more

Experience 108 results

Experience

|

May 27, 2025

PicoCELA Inc. Closes $1.8 Public Offering

Experience

|

April 11, 2025

Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering

Experience

|

April 10, 2025

Titan Acquisition Corp Announces Closing of $276,000,000 Initial Public Offering

View All Experience

Insights & News 815 results

Capital Markets & Securities Law Watch

|

July 2, 2025

|

6 Min Read

Former CEO Sentenced to Prison in First-Of-Its-Kind Prosecution Based Exclusively on Rule 10b5-1 Plans

On June 23, 2025, the first-ever prosecution for bad-faith use of 10b5-1 trading plans resulted in Terren Scott Peizer, the former CEO and executive chairman of the publicly traded company Ontrak, Inc., being sentenced to 42 months in prison and ordered to pay $17.9 million in fines and restitution. A California federal district court found that Peizer had entered into Rule 10b5-1 plans in bad faith and while in possession of material nonpublic information to avoid more than $12.5 million in losses related to the termination of a large customer contract.

Competition Corner

|

July 2, 2025

|

10+ Min Read

Spotlight on Japan: Japan’s New Freelance Act – A Comparative Overview with U.S. and EU Legal Frameworks

This post highlights key aspects of the Japan Freelance Act and compares them with relevant legal frameworks in the United States—particularly in California and New York—as well as in Europe with an aim to help businesses operating globally understand the important legal considerations when working with freelance workers across jurisdictions.

Competition Corner

|

July 1, 2025

|

1 Min Read

Takeaways from the ABA Antitrust in the Americas Conference

Sofia Arguello attended the 2025 Antitrust in the Americas Conference. The conference explored the latest in competition, data privacy, and consumer protection across the Americas. It featured in-depth panels on the most pressing competition enforcement and policy issues shaping markets in the region, with insights from top government enforcers, corporate counsel, and leading practitioners. 

View All Insights & News

Other Results 36 results

Site Content

What Is the Price Range in an IPO?

The price range is a proposed price per share range for the IPO within which investors can bid for shares and which is often printed on the cover page of a
preliminary prospectus. The price range has a minimum price, known as the floor price, and a maximum price, known as the cap price.
...Read more

Site Content

What Is the BPCIA?

Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) to provide an abbreviated pathway for biosimilars to gain FDA approval through
submission of an abbreviated Biologics License Application (aBLA).
...Read more

Site Content

What Is Dilution?

Dilution refers to the reduction in an existing shareholder’s ownership percentage of a company when the company issues additional shares. Dilution in an
IPO results from a disparity between the public offering price in an IPO and the effective cash cost to persons who acquired shares prior to the IPO. Dilution is
disclosed in the registration statement in a dilution table.
...Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising

We, our service providers, and other third parties use cookies and other analytics, advertising, and tracking technologies on this site. Your information, including personal information and interactions with this site, may be monitored, recorded, or collected through these tools and further used or disclosed by us, our service providers, and authorized third parties. For more details, please visit our privacy policy.